Viewing Study NCT00055367


Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2025-12-25 @ 11:09 PM
Study NCT ID: NCT00055367
Status: COMPLETED
Last Update Posted: 2016-06-16
First Post: 2003-02-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease
Sponsor: Biogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module